Daljeet Samra, MD
Internal Medicine · Dublin, CANPI 1720229693
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $37,223 of the $39,833 with a category attached, or 93.4%. AbbVie accounts for 94.2% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $19,433 and has fallen 90.0% since, to $1,945 in 2025. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $375.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$38K
- AstraZeneca$552
- Sanofi$345
- GSK$325
- Amgen$225
- Regeneron Healthcare Solutions, Inc.$222
- plus $631 from 12 others
What the payments were for
- Speaking & faculty fees$37,22393%
- Food & beverage$2,5396%
- Education$710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 22 | $37,532 |
| AstraZeneca | 18 | $552 |
| Sanofi | 13 | $345 |
| GSK | 13 | $325 |
| Amgen | 10 | $225 |
| Regeneron Healthcare Solutions, Inc. | 6 | $222 |
| Novartis | 4 | $113 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $113 |
| Pharming Healthcare, Inc. | 3 | $74 |
| CSL Behring | 2 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Azurity Pharmaceuticals, Inc. | 2 | $44 |
| Grifols USA, LLC | 2 | $44 |
| Ionis Pharmaceuticals, Inc. | 1 | $38 |
| Alk-abello, Inc | 1 | $25 |
| Optinose US, Inc. | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| LEO Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$125
- FASENRA$101
- AIRSUPRA$101
- TEZSPIRE$101
How this compares
$39,833 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Dublin
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Hatim HusainSan Diego$2M
- Teck LingPalo Alto$1.1M
- Hyong Kimla Jolla$1M
- Rohit Loombala Jolla$965K
- Fred CohenSan Francisco$929K
- Steven EdelmanSan Diego$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.